Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
2.140
-0.060 (-2.73%)
At close: Jul 24, 2026, 4:00 PM EDT
2.160
+0.020 (0.93%)
After-hours: Jul 24, 2026, 7:42 PM EDT

CNTB Stock Forecast

Stock Price Forecast

According to 8 analysts polled by S&P Global, CNTB stock has a consensus rating of "Strong Buy" and an average price target of $7.13. The average 1-year stock price forecast is 233.18% higher than the current stock price, while the lowest is $4.00 (+86.92%) and the highest is $10 (+367.29%).

Price Target: $7.13 (+233.18%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$4.00$7.13$7.00$10
Change+86.92%+233.18%+227.10%+367.29%

Analyst Ratings

The average analyst rating for CNTB stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingFeb '26Mar '26Apr '26May '26Jun '26Jul '26
Strong Buy555767
Buy000011
Hold000000
Sell000000
Strong Sell000000
Total555778

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Lake Street
Lake Street
Buy
Maintains
$9
BuyMaintains$9+320.56%Jul 15, 2026
Oppenheimer
Oppenheimer
Buy
Initiates
$8
BuyInitiates$8+273.83%Jul 9, 2026
Canaccord Genuity
Canaccord Genuity
Buy
Maintains
$6
BuyMaintains$6+180.37%Jun 30, 2026
Piper Sandler
Piper Sandler
Buy
Initiates
$7
BuyInitiates$7+227.10%Jun 26, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$7
BuyReiterates$7+227.10%Jun 25, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
6.07M
from 64.00K
Increased by 9,376.76%
Revenue Next Year
10.88M
from 6.07M
Increased by 79.44%
EPS This Year
-0.15
from -0.14
EPS Next Year
-0.12
from -0.15
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingJan 1, 2022Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
---26.03M64.00K6.07M
Revenue Growth
-----99.75%9,376.76%
Operating Income
-97.66M-116.36M-69.06M-19.25M-58.07M-73.49M
Net Income
-202.27M-118.09M-62.11M-15.63M-55.48M-72.48M
EPS
-----0.14-0.15
Free Cash Flow
-46.03M-67.55M-25.55M-21.10M-30.65M-72.91M
No. Analysts
-----8
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High15.0M
Avg6.1M
Low196,017

Revenue Growth

Revenue Growth202620272028
High
23,287.2%
Avg
9,376.8%
Low
206.3%

EPS Forecast

EPS202620272028
High-0.12
Avg-0.15
Low-0.17

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-